Sg3 Management, LLC Sarepta Therapeutics, Inc. Transaction History

Sg3 Management, LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$62.69 - $88.44 $626,900 - $884,400	-10,000 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$63.15 - $90.42 $410,475 - $587,730	6,500 Added 185.71%	10,000 $781,000
Q4 2021 Feb 15, 2022	SELL	$77.28 - $99.42 $425,040 - $546,810	-5,500 Reduced 61.11%	3,500 $315,000
Q3 2021 Nov 15, 2021	SELL	$65.97 - $92.48 $329,850 - $462,400	-5,000 Reduced 35.71%	9,000 $832,000
Q1 2021 May 17, 2021	BUY	$72.25 - $168.95 $794,750 - $1.86 Million	11,000 Added 366.67%	14,000 $1.04 Million
Q4 2020 Feb 16, 2021	SELL	$125.56 - $178.74 $125,560 - $178,740	-1,000 Reduced 25.0%	3,000 $511,000
Q3 2020 Nov 13, 2020	BUY	$127.12 - $172.34 $317,800 - $430,850	2,500 Added 166.67%	4,000 $562,000
Q2 2020 Aug 14, 2020	BUY	$93.0 - $171.7 $139,500 - $257,549	1,500 New	1,500 $241,000
Q1 2019 May 14, 2019	SELL	$106.67 - $151.68 $533,350 - $758,400	-5,000 Closed	0 $0
Q4 2018 Feb 12, 2019	BUY	$97.32 - $148.76 $486,599 - $743,800	5,000 New	5,000 $546,000
Q4 2017 Feb 13, 2018	SELL	$47.64 - $56.75 $166,740 - $198,625	-3,500 Closed	0 $0
Q3 2017 Jan 25, 2018	BUY	$35.73 - $47.15 $125,054 - $165,025	3,500	3,500 $159,000

530

84.5M

2.06M

1.52M

Ticker SRPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,567,904
Market Cap $12.1B
Description
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...

Get notified when there are updates to the investment portfolio of Sg3 Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Sg3 Management, LLC with notifications on news.